Supporting Breast Cancer Research at the University of Michigan
There has never been a more exciting, promising moment in breast cancer research. The U-M Comprehensive Cancer Center is leading the world in discovering and developing personalized cancer therapies, anchored by its Breast Oncology Program. Perhaps more than any other academic institution in the country, U-M cancer scientists are poised to revolutionize the way breast cancer is treated.
The U-M's multifaceted and revolutionary approach to breast cancer — from molecular-based, personalized therapies to addressing the whole family's quality of life — make this the place for tomorrow's cancer care.
As we stand on the brink of phenomenal advances, greater investment in breast cancer research is needed now.
An investment in the U-M Breast Oncology Program is an unprecedented opportunity to define the future of breast cancer care around the world. The time is now to transform our groundbreaking discoveries into patient care as quickly as possible. The millions of women, families and communities affected by breast cancer should not have to wait.
Join us in creating the future of breast cancer care.
Max Wicha, M.D.
Director, U-M Comprehensive Cancer Center
Distinguished Professor of Oncology
Daniel F. Hayes, M.D.
Clinical Director, Breast Oncology Program
Stuart B. Padnos Professor of Breast Cancer Research
Sofia Merajver, M.D., Ph.D.
Scientific Director, Breast Oncology Program
Director, Breast and Ovarian Cancer Risk Evaluation Program
Professor of Internal Medicine
Lisa Newman, M.D., M.P.H., F.A.C.S
Director, U-M Breast Care Center
Professor of Surgery